| Alpine Eye Care | |
|
350 W North St, Gaylord, MI 49735-1525 | |
| (989) 732-6455 | |
| (989) 732-1102 |
| Full Name | Alpine Eye Care |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 350 W North St, Gaylord, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215065727 | NPI | - | NPPES |
| 180F910770 | Other | MI | BCBS OD |
| 1806920011 | Other | MI | BLUE CARE NETWORK |
| 3038315 | Medicaid | MI | |
| 180F910760 | Other | MI | BCBS MD |
| CJ0562 | Other | MI | RAILROAD MEDICARE |
| 900F910770 | Other | MI | BLUE CARE NETWORK |
| 900F910770 | Other | MI | BCBS |
| 1806920011 | Other | MI | BCBS |
| Provider Name | William R Shouldice |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275611246 PECOS PAC ID: 6800981374 Enrollment ID: I20070927000965 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Michael L Habryl |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1437470325 PECOS PAC ID: 4587856562 Enrollment ID: I20101008000600 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Jeffrey Kenneth Chaulk |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1710925334 PECOS PAC ID: 0749381895 Enrollment ID: I20101119000443 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Brian Wade |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1306255187 PECOS PAC ID: 8224258637 Enrollment ID: I20141007002374 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Roxanne Rottiers |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205212131 PECOS PAC ID: 2264746932 Enrollment ID: I20150810000527 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Dan James St Aubin |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1699115675 PECOS PAC ID: 3971807355 Enrollment ID: I20170606002105 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Peter Dunsmore Lawrence |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346814613 PECOS PAC ID: 7416356282 Enrollment ID: I20210527000876 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Provider Name | Kevin Bradley Lodewyk |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1255851952 PECOS PAC ID: 1850661059 Enrollment ID: I20220418001254 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alpine Eye Care Po Box 1665, Gaylord, MI 49734-5665 Ph: (989) 732-6455 | Alpine Eye Care 350 W North St, Gaylord, MI 49735-1525 Ph: (989) 732-6455 |
News Archive
Beginning July 1, 2010, Independence Blue Cross (IBC) will offer five new Personal Choice® PPO plan options for individuals – expanding the range of individual plan choices for health care consumers in the region. These medically underwritten plans are available in three popular formats: copay, deductible and health savings account (HSA) plan designs that enable consumers to choose the type of plan and pricing that fits their specific needs.
Martha Phillips knows exactly how it feels to suddenly find oneself up close to — and unprotected from — a deadly virus.
Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 6 days ago